SCHEMBL5319451

SCHEMBL5319451

CCCCCCCCCc1ccc(O)c(C(C)(C)c2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT8 Q9H7Z6 2/20 0.52
PPARA Q07869 2/20 0.49
IGF1R P08069 1/20 0.46
ALOX15 P16050 1/20 0.46
ESR1 P03372 2/20 0.45
ADRA2A P08913 2/20 0.45
ADORA3 P0DMS8 2/20 0.45
TACR2 P21452 2/20 0.45
SLC6A2 P23975 2/20 0.45
SLC6A4 P31645 2/20 0.45
SLC6A3 Q01959 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
SHBG P04278 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
HSPD1 P10809 1/20 0.45
ADRB3 P13945 1/20 0.45
HTR2C P28335 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31528718 1.00 KAT8 (0.52) KAT8PPARAIGF1RALOX15ESR1
SCHEMBL28812905 0.94 IGF1R (0.45) KAT8PPARAIGF1RALOX15
SCHEMBL11794148 0.88 KAT8 (0.56) KAT8PPARAIGF1RALOX15ESR1
SCHEMBL19056632 0.86 PTGS2 (0.47) KAT8PPARAESR1ADRA2AADORA3
SCHEMBL989124 0.84 KCNH2 (0.47) KAT8PPARAIGF1RALOX15ESR1
SCHEMBL9588955 0.83 GPR3 (0.42) KAT8PPARAESR1ADRA2AADORA3
SCHEMBL5693437 0.82 ALDH1A1 (0.49) PPARAIGF1RALOX15ESR1KDM4E
SCHEMBL107937 0.82 KAT8 (0.56) KAT8PPARAIGF1RALOX15ESR1
SCHEMBL8975192 0.82 KAT8 (0.56) KAT8PPARAIGF1RALOX15ESR1
SCHEMBL106675 0.82 KAT8 (0.56) KAT8PPARAIGF1RALOX15ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181481-B2 Liquid crystal display device and method of manufacturing the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-11-10 US claimed
EP-4490508-A1 OXIDATIVE STABILITY TEST METHODS FOR CHEMICALLY RECYCLED PLASTIC FEEDSTOCKS ECOLAB USA INC. (US) 2025-01-15 EP disclosed
EP-4456900-A1 RESPIRATORY STIMULANT PARENTERAL FORMULATIONS Enalare Therapeutics Inc. (US) 2024-11-06 EP disclosed
US-20240200242-A1 KNIT TEXTILES AND UPPERS, AND PROCESSES FOR MAKING THE SAME NIKE, INC. 2024-06-20 US disclosed
EP-4305128-A1 STABILIZER ADDITIVES FOR PLASTIC-DERIVED SYNTHETIC FEEDSTOCK ECOLAB USA INC. (US) 2024-01-17 EP disclosed
WO-2023172410-A1 OXIDATIVE STABILITY TEST METHODS FOR CHEMICALLY RECYCLED PLASTIC FEEDSTOCKS ECOLAB USA INC. (US) 2023-09-14 WO disclosed
WO-2023129502-A1 RESPIRATORY STIMULANT PARENTERAL FORMULATIONS ENALARE THERAPEUTICS INC. (US) 2023-07-06 WO disclosed
WO-2022192577-A1 STABILIZER ADDITIVES FOR PLASTIC-DERIVED SYNTHETIC FEEDSTOCK ECOLAB USA INC. (US) 2022-09-15 WO disclosed
US-10035970-B2 Friction-reducing compound, method of producing same, and lubricant composition BASF SE (DE) 2018-07-31 US disclosed
US-20180201866-A1 COMPOSITION AND METHOD OF FORMING THE SAME BASF SE (DE) 2018-07-19 US disclosed
EP-0345220-A2 Polyamines partially substituted by bis-piperidyl-triazines CIBA-GEIGY AG (CH) 1989-12-06 EP disclosed
EP-0345221-A2 Polyamines partially substituted by piperidine-triazines CIBA-GEIGY AG (CH) 1989-12-06 EP disclosed
EP-0337431-A2 Stabilized styrene copolymer comprising elastomer particles CIBA-GEIGY AG (CH) 1989-10-18 EP disclosed
EP-0317508-A2 Aminic orthoester stabilized compositions CIBA-GEIGY AG (CH) 1989-05-24 EP disclosed
EP-0314623-A2 Substituted hydroxylamine ester stabilizers CIBA-GEIGY AG (CH) 1989-05-03 EP disclosed
EP-0313517-A2 Aliphatic esters of 1,3,2-oxazaphospholidines CIBA-GEIGY AG (CH) 1989-04-26 EP disclosed
EP-0302007-A1 Hydroxyether-carboxylic acids and lactones thereof, process for their production and their use as corrosion inhibitors CIBA-GEIGY AG (CH) 1989-02-01 EP disclosed
EP-0296112-A2 Storage-stable curable compositions CIBA-GEIGY AG (CH) 1988-12-21 EP disclosed
EP-0292438-A1 Functional fluids FMC CORPORATION (UK) LIMITED (GB) 1988-11-23 EP disclosed
EP-0290386-A2 Stabilization of organic polymers against light degradation CIBA-GEIGY AG (CH) 1988-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180201866-A1 COMPOSITION AND METHOD OF FORMING THE SAME DSP, TST, MPST KAT8 2455/4885PPARA 1174/4885IGF1R 4831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.